The Alliance for Aging Research submitted a letter to the Patient-Centered Outcomes Research Institute (PCORI) suggesting possible research for the Institute to consider, aimed at improving outcomes for people with Alzheimer's disease. The Alliance encouraged the following topics:
Impact of non-pharmacologic interventions for Alzheimer’s disease on patient outcomes, caregiver burden and rates of institutionalization
Evaluation of screening methodologies, for relative ease/uptake and associated optimization across provider groups and settings of care;
Assessment of how Alzheimer’s disease diagnosis and treatment affects management of comorbidities;
Frequency of emergency room visits for Alzheimer’s disease patients and identification of
best practices for potential mitigation;
Comparisons of currently available tools used to assess cognition to identify which is most
effective for specific populations; and
Impact of knowing positive ApoE genotype status on patient, caregiver, and provider
behaviors/outcomes as compared to ApoE negative status.
At last month's annual dinner, the Alliance gave eminent Harvard researcher Rudolph E. Tanzi. Ph.D., the Silver Innovator Award for spearheading his research lab’s “Alzheimer’s-in-a-dish model,” a revolutionary 3-D discovery that gives new hope for the development of therapies to treat and cure the condition.
This annual Alzheimer’s Drug Discovery Foundation (ADDF) conference brings together academic and industry scientists intent on accelerating the development of innovative treatments for Alzheimer’s disease and related dementias. Participate in this exclusive opportunity to hear presentations by ADDF-funded investigators on the forefront of finding treatments for Alzheimer’s disease and related dementias.
Sign up for our email newsletter, Living Longer & Loving It, for the latest information on scientific research on aging and health.